Conclusion

Philip G. Janicak*, Stephen R. Marder, Rajiv Tandon, Morris Goldman

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Several recent initiatives in the diagnosis and treatment of schizophrenia continue to offer hope for patients suffering from this often devastating illness. These include a reconceptualization of how schizophrenia is diagnosed with a gradual shift from clinical symptom criteria to measurement-based approaches and the use of biological markers. Another major focus is early identification of at-risk and first-episode individuals. This allows for more timely monitoring and treatment interventions which may preclude the evolution into more chronic, less treatment responsive stages of the illness. Finally, strategies to moderate the impact of recurrent episodes, improve functionality, and enhance quality of life should help facilitate the achievement of important personal goals as our patients work towards recovery.

Original languageEnglish (US)
Title of host publicationSchizophrenia
Subtitle of host publicationRecent Advances in Diagnosis and Treatment
PublisherSpringer New York
Pages315-320
Number of pages6
ISBN (Electronic)9781493906567
ISBN (Print)1493906550, 9781493906550
DOIs
StatePublished - Feb 1 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Conclusion'. Together they form a unique fingerprint.

  • Cite this

    Janicak, P. G., Marder, S. R., Tandon, R., & Goldman, M. (2014). Conclusion. In Schizophrenia: Recent Advances in Diagnosis and Treatment (pp. 315-320). Springer New York. https://doi.org/10.1007/978-1-4939-0656-7_15